According to the lawsuit, Sanofi and Boehringer “knew or had reason to know” that consumers who took Zantac were exposed to “unsafe levels” of NDMA yet failed to disclose the risk on the drug’s labels or by any other means.“Had Defendants disclosed that Zantac results in unsafe levels of NDMA in the human body, no person, let alone a reasonable person, would have purchased and consumed Zantac,” the lawsuit states.According to suit, NDMA belongs to a family of chemicals, N-nitrosamines, recognized by the U.S. Environmental Protection Agency (EPA) and World Health Organization (WHO) as carcinogenic. Four plaintiffs filed a legal complaint against Sanofi and Boehringer Ingelheim. According to the case, an individual who takes a 150 mg maintenance dose of Zantac once daily is exposed to 0.889 grams of NDMA over the course of a year.The lawsuit asks the court to certify a proposed class of consumers who bought the over-the-counter version of Zantac in California at any time between January 1, 2010, and the present.This browser does not support PDFs. Ranitidine blocks these receptors, and prevents histamine from producing its normal effect, which causes the stomach to produce less acid.The manufacturers of Zantac and generic ranitidine products have warned patients and healthcare providers about the following potential side effects, but to this day have never warned about any potential exposure to a carcinogen:Some plaintiffs have already filed lawsuits against the makers of Zantac and of generic ranitidine, and more are expected to be filed in the future. Message. Cancel Post Info. A histamine chemical normally stimulates these receptors to produce acid to the body help digest food. Recently, multiple ranitidine and Zantac manufacturers recalled their products due to concerns that they contain high levels of NDMA, a carcinogen. • This means that all manufacturers, brand or generic, and all lots of ranitidine-containing medications are affected and could generate very high levels of NDMA in the human body.”Significantly, ranitidine interacts with the stomach in a warm environment, and that heat could potentially transform the drug into NDMA during the digestive process, though we are still waiting on studies to confirm this.Meanwhile, France, Canada, Austria, and other countries have recalled all forms of ranitidine from their markets after detecting NDMA. The drug remains available in the U.S., though many major drugstore chains, including CVS and Walgreens, pulled Zantac and generic versions of the heartburn drug from their shelves.Types of injuries associated with Zantac and generic forms of ranitidine may include:Zantac, the most popular brand of ranitidine, is used to help reduce stomach acid. We apologize for any inconvenience.There is currently no drug history available for this drug.There are no additional details available for this product.This website is intended for informational and entertainment purposes only and is not intended to replace any professional medical advice.This field is for validation purposes and should be left unchanged. Press release from ACTO The 31-page complaint out of California’s Northern District alleges that Zantac (ranitidine) has become one of the most widely used and highest-selling drugs in the United States due in part to defendants Sanofi-Aventis U.S. and Boehringer Ingelheim Pharmaceuticals’ “deception” in failing to disclose to consumers the product’s NDMA content.

Last updated on Nov 20, 2019. Maximum Strength Zantac.